3553 results for «2290»
3553 results
Challenges in the treatment of patients with left main disease
21 May 2025 – From EuroPCR 2025
Address the challenges in treating patients with left main disease by reviewing bifurcation techniques, intravascular imaging complexities, and intervention dilemmas in renal patients. Cases highlight management of calcified left main disease post-STEMI and nuanced lesion presentations.
Novelties and future developments of sympathetic denervation to control blood pressure
21 May 2025 – From EuroPCR 2025
Discover the latest novelties and future directions in sympathetic denervation for blood pressure control. This session presents preclinical safety data, lesion characteristics, anatomic guidance innovations, multi-organ denervation pilot studies, and breakthrough technologies like the Electroducer sleeve to enhance renal denervation interventions.
Non-antiplatelet drugs interventionalists should be aware of
21 May 2025 – From EuroPCR 2025
Gain essential knowledge on non-antiplatelet drugs relevant to interventional cardiology. Topics include the effects of empagliflozin on oxidative stress, the impact of midazolam on radial spasm during primary PCI, pharmacological cocktails to prevent radial spasm, and hydration strategies in patients with kidney disease during cardiac catheterisation.
Left main stenting techniques
21 May 2025 – From EuroPCR 2025
Examine advanced left main stenting techniques including DK crush and mini-crush strategies for complex bifurcation lesions. This session reviews stent malapposition in trifurcations, novel stent expansion outcomes, bifurcation angle correlations, and clinical results of double kissing crush versus culotte techniques.
Unusual STEMI presentations: coronary embolism
21 May 2025 – From EuroPCR 2025
Investigate unusual STEMI presentations caused by coronary embolism through compelling case studies. Topics include differentiating thrombus from embolism, myocardial infarction after TAVI, paradoxical coronary embolism, septic emboli complications, and complex STEMI scenarios in TAVI patients.
Imaging skills for successful TAVI procedure
21 May 2025 – From EuroPCR 2025
Enhance your imaging skills essential for successful TAVI procedures. This session covers complex scenarios such as left circumflex coronary artery anomalies, valve infolding risks with new platforms, bioprosthesis dysfunctions, procedural adaptations when faced with challenges, and zero-contrast TAVI techniques.
Complications management in NSTEMI patients
21 May 2025 – From EuroPCR 2025
Explore effective management strategies for complications in NSTEMI patients through real-life complex cases. Topics include saphenous vein graft stenting challenges, dislodged stents, rare coronary bifurcation perforations, and solutions for graft blockage with covered stents.
Acute and late coronary complications post-TAVI
21 May 2025 – From EuroPCR 2025
Gain insights into acute and late coronary complications following TAVI. This session discusses angina post-TAVI, mechanisms of acute severe mitral regurgitation during TAVR, hidden coronary obstructions, sudden hemodynamic collapse, and acute coronary occlusion after balloon aortic valvuloplasty.
TEER for challenging anatomy: from myth to reality
21 May 2025 – From EuroPCR 2025
Explore advanced TEER techniques for challenging anatomies. This session covers indications, periprocedural steps, state-of-the-art procedural methods, and management of failed surgical tricuspid annuloplasty, with case discussions highlighting practical learnings for complex mitral and tricuspid interventions.
Treatment and prognostic stratification of ACS patients with cardiogenic shock
21 May 2025 – From EuroPCR 2025
This session focuses on treatment and prognostic stratification in ACS patients complicated by cardiogenic shock. Topics include mechanical CPR device performance, SCAI shock grade dynamics, hemorrhagic event predictors, ECMO-related strategies, and evaluation of BCIS conveyance algorithms for out-of-hospital cardiac arrest.
Techniques and decision making in management of coronary bifurcation lesion
20 May 2025 – From EuroPCR 2025
Explore advanced techniques and decision-making processes in managing coronary bifurcation lesions. This session covers high-risk PCI in calcified left main bifurcations, distal wire anchoring for angulated vessels, and the use of drug-coated balloons to simplify complex ostial lesions, providing valuable insights for optimizing bifurcation PCI outcomes.
Which device for which patient: DES, BRS or DCB?
22 May 2025 – From EuroPCR 2025
This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.
High thrombus burden in STEMI
22 May 2025 – From EuroPCR 2025
This session addresses the management of high thrombus burden in STEMI patients. It reviews available tools and strategies for thrombus management, presents multiple case-based discussions illustrating treatment decisions, and explores the evolving role of thrombus aspiration in contemporary practice.
Innovative strategies for coronary interventions
22 May 2025 – From EuroPCR 2025
Explore innovative strategies in coronary interventions, including the EPIC26 sirolimus-eluting stent study, use of percutaneous ventricular assist devices in high-risk patients, the SCORE multicenter study on SeQuent SCB, DCB versus DES for ostial left circumflex lesions, and site-specific antithrombotic therapy outcomes from the DESyne BDS Plus...
Artificial intelligence in the cathlab
22 May 2025 – From EuroPCR 2025
Delve into the transformative role of artificial intelligence (AI) in the cathlab. This session covers AI applications for vulnerable plaque identification using intracoronary OCT, automated coronary angiogram analysis, rapid AI-based OCT interpretation, AI-enhanced decision-making for PCI optimization, and noninvasive microvascular resistance assessment powered by AI.
Emerging indications for TAVI in 2025
22 May 2025 – From EuroPCR 2025
Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.
Deep dive on pulmonary embolism catheter technologies - Clinical trial data and how to use
22 May 2025 – From EuroPCR 2025
Deep dive into pulmonary embolism catheter technologies through case-based presentations. Learn about established and novel devices for acute pulmonary embolism treatment, indications for device use, and management of procedural complications to optimize patient outcomes.
Risk stratification of NSTEMI patients
22 May 2025 – From EuroPCR 2025
Explore the latest insights on risk stratification in NSTEMI patients through comparative analysis of established risk scores such as GRACE, HEART, and TIMI in predicting coronary artery disease severity. This session also reviews outcomes based on diabetes status and left ventricular ejection fraction, prospective validation of...
TAVI in women
22 May 2025 – From EuroPCR 2025
Focus on gender-specific considerations in TAVI with this session. Topics include timely management and referral disparities in women with severe aortic stenosis, early outcomes from the LANDMARK trial with latest-generation valves, insights from NAVULTRA comparing valve types, prosthesis-patient mismatch data, and gender differences in right ventricular...
Is DCB a new valid option for coronary revascularisation?
22 May 2025 – From EuroPCR 2025
This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...
